Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Lynn Raymond"'
Autor:
Anne Rosser, Roger Alistair Barker, Thomas Warner, Lynn Raymond, Judith Bek, Jane Paulsen, Jeffrey Long, Janet Karen Williams, Vincent Magnotta
Publikováno v:
European Journal of Human Genetics
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM
Autor:
Haller, Gary J., Lynn, Raymond J.
Publikováno v:
The Journal of Infectious Diseases, 1968 Apr 01. 118(2), 160-164.
Externí odkaz:
https://www.jstor.org/stable/30102478
Autor:
Eric Epping, Anne Rosser, Nellie Georgiou-Karistianis, Roger Alistair Barker, Stacie Vik, Mirza Faisal Beg, Blair Leavitt, Katherine Koenig, Julie Stout, David Moser, Lynn Raymond, Anita Goh, Phyllis Chua, Hans Johnson, Thomas Wassink, Nicole Mans, WR Wayne Martin, Carissa Gehl, Michael Hayden, Georg Bernhard Landwehrmeyer, Jane Paulsen, Jeffrey Long, Vincent Magnotta, Jess Fiedorowicz
Publikováno v:
Neurobiology of Disease, Vol 46, Iss 3, Pp 625-634 (2012)
Leukocyte 8-hydroxydeoxyguanosine (8OHdG) is an indicator of oxidative stress, impaired metabolism, and mitochondrial dysfunction, features that have been implicated in Huntington disease (HD). Increased levels of 8OHdG have been reported in the caud
Autor:
Eric Epping, Anne Rosser, Nellie Georgiou-Karistianis, Roger Alistair Barker, Stacie Vik, Mirza Faisal Beg, Katherine Koenig, Julie Stout, Deborah Harrington, David Moser, Lynn Raymond, Judith Bek, Anita Goh, Phyllis Chua, Hans Johnson, Thomas Wassink, WR Wayne Martin, Carissa Gehl, Michael Hayden, Georg Bernhard Landwehrmeyer, Jane Paulsen, Jeffrey Long, Samantha Loi, Janet Karen Williams, Vincent Magnotta, Jess Fiedorowicz
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 83:612-619
BACKGROUND: Prodromal Huntington's disease (prHD) is associated with a myriad of cognitive changes but the domains that best predict time to clinical diagnosis have not been studied. This is a notable gap because some domains may be more sensitive to
Autor:
Anne-Catherine Bachoud-Lévi, Lynn Raymond, Jerome De Seze, Carissa Gehl, Francis Walker, Kathleen Shannon, Jane Paulsen
Publikováno v:
Psychiatry Research. 188:372-376
Huntington disease (HD) is a neurodegenerative condition characterized by cognitive impairments, motor abnormalities, and psychiatric disturbance. An increased risk for suicide has been documented. The majority of HD research has focused on cognitive
Autor:
Peggy Nopoulos, Anne Rosser, Stefan Klöppel, Roger Alistair Barker, Stacie Vik, Douglas Langbehn, Thomas Warner, Lynn Raymond, Hans Johnson, Georg Bernhard Landwehrmeyer, Jane Paulsen, Vincent Magnotta
Publikováno v:
Neurobiology of Disease, Vol 40, Iss 3, Pp 544-554 (2010)
Neuroimaging studies of subjects who are gene-expanded for Huntington Disease, but not yet diagnosed (termed prodromal HD), report that the cortex is "spared," despite the decrement in striatal and cerebral white-matter volume. Measurement of whole-c
Autor:
Eric Epping, Peggy Nopoulos, Anne Rosser, Nellie Georgiou-Karistianis, Stefan Klöppel, Roger Alistair Barker, Stacie Vik, Yongxia (Sharon) Zhou, Mirza Faisal Beg, Douglas Langbehn, Thomas Warner, Julie Stout, David Moser, Lynn Raymond, Ergun Uc, Anita Goh, Phyllis Chua, Hans Johnson, Kylie Radford, Thomas Wassink, Alexandra Margaret Ure, Charlotte Soneson, William Coryell, Carmela Pestell, WR Wayne Martin, Michael Hayden, Georg Bernhard Landwehrmeyer, Jane Paulsen, Vincent Magnotta
Publikováno v:
Neurobiology of Disease, Vol 40, Iss 3, Pp 531-543 (2010)
Huntington disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG repeat. Its length can be used to estimate the time of clinical diagnosis, which is defined by overt motor symptoms. Non-motor symptoms begin before motor onset,
Autor:
Peggy Nopoulos, Anne Rosser, Nellie Georgiou-Karistianis, Stefan Klöppel, Roger Alistair Barker, Stacie Vik, Douglas Langbehn, Thomas Warner, Julie Stout, David Moser, Lynn Raymond, Ergun Uc, Anita Goh, Phyllis Chua, Hans Johnson, Kylie Radford, Alexandra Margaret Ure, William Coryell, WR Wayne Martin, Michael Hayden, Georg Bernhard Landwehrmeyer, Jane Paulsen, J. Timothy Greenamyre, Janet Karen Williams, Vincent Magnotta
Publikováno v:
Movement Disorders. 25:2595-2603
The basic aim of this study was to evaluate the current accepted standard clinical endpoint for the earliest-studied HD participants likely to be recruited into clinical trials. As the advent of genetic testing for HD, it is possible to identify gene
Autor:
Anne-Catherine Bachoud-Lévi, Kelly Ormond, Lynn Raymond, Carissa Gehl, Francis Walker, Jane Paulsen
Publikováno v:
Journal of Nervous & Mental Disease. 198:334-338
Although current reports document a high rate of obsessive and compulsive symptoms (O/Cs) in Huntington's disease (HD), there have been no studies published that have made an attempt to identify comorbidities of O/Cs in HD. We examined O/Cs in 1642 i
Autor:
Anne Rosser, Stefan Klöppel, Roger Alistair Barker, Stacie Vik, Douglas Langbehn, Thomas Warner, Julie Stout, Lynn Raymond, Hans Johnson, Michael Hayden, Georg Bernhard Landwehrmeyer, Jane Paulsen, Vincent Magnotta
Publikováno v:
Movement Disorders. 24:1763-1772
The PREDICT-HD study seeks to identify clinical and biological markers of Huntington's disease in premanifest individuals who have undergone predictive genetic testing. We compared baseline motor data between gene-expansion carriers (cases) and nonge